stockrowOPKO Health, Inc. (OPK) vs Veracyte, Inc. (VCYT)
- OPKO Health, Inc. OPK 1.74 −0.57%
- Veracyte, Inc. VCYT 24.14 +0.58%
OPKO Health, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. Veracyte, Inc. is the larger, with a market value of $1.9B against $1.3B — 1.5× the size. OPKO Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 15.2×. Veracyte, Inc. grew revenue faster over the last twelve months: 17.5% against −21.9%. Veracyte, Inc. has the higher net margin (21.8% vs −29.5%) and the higher return on invested capital (4.33% vs −6.72%). Across the 18 metrics below, Veracyte, Inc. leads on 16 and OPKO Health, Inc. on 2.
Valuation
Profitability
| Metric | OPK | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 46.22% | 71.98% | 48.32% |
| Operating margin | (25.46%) | 17.08% | (5.68%) |
| Net margin | (29.51%) | 21.80% | (4.10%) |
| Free cash flow margin | (26.91%) | 27.84% | 0.00% |
| Return on equity | (12.23%) | 9.43% | 0.00% |
| Return on assets | (7.64%) | 8.63% | (6.05%) |
| Return on invested capital | (6.72%) | 4.33% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack